Navigation Links
Gates Foundation Now Accepting Proposals for Grand Challenges Explorations
Date:3/31/2008

SEATTLE, March 31 /PRNewswire/ -- The Bill & Melinda Gates Foundation announced today that it is now accepting grant proposals for the first round of Grand Challenges Explorations, a US$100 million initiative to encourage bold and unconventional global health solutions. Proposals will be accepted online at http://www.gcgh.org/explorations through May 30, 2008; applicants must register their intent to submit a proposal by May 15, 2008.

The initiative, the first of its kind for the foundation, uses an agile, accelerated grant-making process. Applications are two pages, and preliminary data about the proposed research are not required. One of the primary objectives of Grand Challenges Explorations is to involve scientists around the world who don't typically work in global health -- this includes innovators in Africa, Asia, and other parts of the developing world; those from complementary disciplines and in the private sector; and young investigators.

The first four topic areas for which proposals will be accepted through the Grand Challenges Explorations initiative are:

-- Creating new ways to protect against infectious diseases, including

alternatives to traditional vaccination.

-- Creating new drugs and delivery systems to limit the emergence of

resistance from developing in the disease-causing agent.

-- Creating new ways to prevent or cure HIV infection that fall outside

current research on vaccines, antiretroviral drugs, and other

biomedical and behavior-change strategies.

-- Exploring the basis for latency in TB, with the goal of discovering new

ways to identify and eliminate latent infection, and break the cycle of

TB transmission.

The foundation and an independent group of reviewers will select the most innovative proposals, and grants will be awarded within approximately three months from the proposal submission deadline. Initial grants will be $100,000 each. Projects showing success will have the opportunity to receive additional funding of $1 million or more.

Full descriptions of these topic areas and application instructions are available at http://www.gcgh.org/explorations.

Guided by the belief that every life has equal value, the Bill & Melinda Gates Foundation works to help all people lead healthy, productive lives. In developing countries, it focuses on improving people's health and giving them the chance to lift themselves out of hunger and extreme poverty. In the United States, it seeks to ensure that all people -- especially those with the fewest resources -- have access to the opportunities they need to succeed in school and life. Based in Seattle, the foundation is led by CEO Patty Stonesifer and co-chair William H. Gates Sr., under the direction of Bill and Melinda Gates and Warren Buffett.


'/>"/>
SOURCE Bill & Melinda Gates Foundation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. George Institute receives Gates Foundation grant to survey funding flows
2. Mass. General Hospital receives Gates Foundation grant to expand HIV controllers study
3. Gates Foundation Statement on House Committee Action on Global AIDS, TB, and Malaria
4. Anapol Schwartz Attorney Representing Trasylol(R) Victims Says Medical Study - Confirming Heart Bypass Drug Mortality Risk - to Open Floodgates for More Litigation
5. NIH, Gates Foundation to support Riley Hospital and MoiU Program For Woman and Infant Health Researc
6. Study investigates cannabis use among university students
7. Weill Cornell receives $2.4 million in grants from Gates Foundation to fight tuberculosis
8. HIV Collaborative Fund Receives Gates Foundation Grant for AIDS Treatment and Prevention Advocacy
9. Infectious Disease Research Institute Receives Grant from the Bill & Melinda Gates Foundation for Adjuvant Access and Development
10. Rotary International and Gates Foundation Together Commit $200 Million to Eradicate Polio
11. Gates Foundation Commits to Expansion of HIV Prevention in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2017)... ... 22, 2017 , ... “To Walk Away”: a captivating and romantic sequel ... Koontz. “To Walk Away” is the creation of published author, Larry R. Sherman, a ... manuscripts in chemistry and religion, as well as four novels. , Though the ...
(Date:8/22/2017)... ... August 22, 2017 , ... “Covert Awakening”: Walid’s spiritual ... published author, Julianne Hale, a consultant for the Intelligence Community. For more ... on the Near East region. Julianne has written hundreds of reports for ...
(Date:8/22/2017)... (PRWEB) , ... August 22, 2017 , ... TopConsumerReviews.com recently ... to fight Fatigue . , As the stress of modern life continually makes ... the pace. Constant use of artificial stimulants can trap people in vicious high/low cycles ...
(Date:8/21/2017)... ... , ... PracticeMatch, a company that provides online resources , job ... practitioners like nurse practitioners and physician assistants , will conduct its ... year. The online career fairs will allow job seekers to connect with healthcare employers ...
(Date:8/21/2017)... ... August 21, 2017 , ... Los ... plastic surgery fellows for academic year 2017-2018, Christina M. Busuito, M.D. and Lukasz ... completed residency in Plastic and Reconstructive Surgery. The candidate will have the ...
Breaking Medicine News(10 mins):
(Date:7/26/2017)... E.I. Medical Imaging (EIMI) has partnered with ... design the worlds first ultrasound system to be used underwater ... habitat. In preparation for a piece produced by Icon ... Dr. Guttridge approached EIMI with the idea of an underwater ... sharks underwater. EIMI ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals ... of our clinical trial evaluating Altemia TM , an ... (SCA) and Sickle Cell Disease (SCD). The SCOT Trial, ... the efficacy and safety of Altemia TM in ... conducted under US IND 125274. ...
(Date:7/25/2017)... CAMBRIDGE, Massachusetts , July 25, 2017 The ... treat rare nervous system diseases, has concluded a worldwide license ... the drug SOM0226 against transthyretin amyloidosis (ATTR). Before this licensing ... in a Phase 2 study conducted in Europe ... the United States ...
Breaking Medicine Technology: